Projects funded by the NCN
The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic approach in the treatment of nociceptive and neuropathic pain
2022/45/B/NZ7/03101
Keywords:
neuropathic pain nociceptive pain multi-target-directed ligands histamine H3 receptor antagonists sigma-1 receptor antagonists μ-opioid receptor agonists
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 10
Call: OPUS 23 - announced on 2022-03-28
Amount awarded: 2 533 291 PLN
Project start date (Y-m-d): 2023-04-03
Project end date (Y-m-d): 2027-04-02
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.